Home/Halozyme Therapeutics/Chase Coffman

CC

Chase Coffman

President of Hypercon™

Halozyme Therapeutics

Therapeutic Areas

Drug Delivery Oncology Immunology Endocrinology

Halozyme Therapeutics Pipeline

Drug	Indication	Phase
HYLENEX® recombinant	Hypodermoclysis and subcutaneous fluid administration	Approved
XYOSTED® CIII	Testosterone replacement therapy	Approved

Leadership Team at Halozyme Therapeutics

President and Chief Executive Officer

Nicole LaBrosse

Chief Financial Officer

Chief Legal Officer

View full Halozyme Therapeutics profile